mGlu2/3 receptor in the prelimbic cortex is implicated in stress resilience and vulnerability in mice

Resilience, referring to achieving a positive outcome in the face of adversity, is a common phenomenon in daily life. Elucidating the mechanisms of stress resilience is instrumental to developing more effective treatments for stress-related psychiatric disorders such as depression. Metabotropic glutamate receptors (mGlu2/3 and mGlu5) within the medial prefrontal cortex (mPFC) have been recently recognized as promising therapeutic targets for rapid-acting antidepressant treatment. In this study, we assessed the functional roles of the mGlu2/3 and mGlu5 within different subregions of the mPFC in modulating stress resilience and vulnerability by using chronic social defeat stress (CSDS) paradigms in mice. Our results showed that approximately 51.6% of the subjects exhibited depression- or anxiety-like behaviors after exposure to CSDS. When a susceptible mouse was confronted with an attacker, c-Fos expression in the prelimbic cortex (PrL) subregion of the mPFC substantially increased. Compared with the resilient and control groups, the expression of mGlu2/3 was elevated in the PrL of the susceptible group. The expression of mGlu5 showed no significant difference among the three groups in the whole mPFC. Finally, we found that the social avoidance symptoms of the susceptible mice were rapidly relieved by intra-PrL administration of LY341495-an mGluR2/3 antagonists. The above results indicate that mGluR2/3 within the PrL may play an important regulatory role in stress-related psychiatric disorders. Our results are meaningful, as they expand our understanding of stress resilience and vulnerability which may open an avenue to develop novel, personalized approaches to mitigate depression and promote stress resilience.

Automated summary

The study assessed the functional roles of mGlu2/3 and mGlu5 within different subregions of the mPFC in modulating stress resilience and vulnerability, with results suggesting that mGlu2/3 in the PrL might play an important regulatory role in stress-related psychiatric disorders. Social avoidance symptoms in susceptible mice were rapidly relieved by intra-PrL administration of an mGluR2/3 antagonist, indicating a potential avenue for developing novel, personalized approaches to mitigate depression and promote stress resilience.